Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations
- 1 May 2002
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 143 (5) , 923-929
- https://doi.org/10.1067/mhj.2002.122168
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Incidence and aetiology of heart failure; a population-based studyEuropean Heart Journal, 1999
- Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activationEuropean Journal of Clinical Investigation, 1998
- Plasma N-Terminal Pro–Brain Natriuretic Peptide and AdrenomedullinCirculation, 1998
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991